18.01.2005 15:03:00
|
CVS Takes a Stand on Patient Choice in Pharmacy Delivery System
Business Editors/Health Editors
WOONSOCKET, R.I.--(BUSINESS WIRE)--Jan. 18, 2005--
Company Voluntarily Exits Toyota Motor Manufacturing Employee Plan to Demonstrate Its Commitment to Patient Care and the Value of Retail
Pharmacy
CVS/pharmacy (NYSE: CVS), America's #1 retail pharmacy will voluntarily exit the pharmacy network established to service Toyota Motor Manufacturing employees in all U.S. manufacturing facilities as of February 18, 2005.
The Toyota plan, administered by Anthem, requires Toyota employees to use mail service for maintenance medications treating chronic conditions, such as hypertension and diabetes. If the employee wishes to fill a maintenance prescription at a local pharmacy, Toyota will not provide coverage.
In January 2004, CVS announced that it would not participate in new prescription benefit programs that mandate filling chronic prescriptions through a mail order service facility. CVS wants to ensure patients have the choice of filling these long-term maintenance medications at either their local community pharmacy or through a mail service pharmacy.
"The primary issue here is patient choice. Consumers should not be subject to plan designs that force them to forfeit choice and their access to a community pharmacist who they value and trust," said Eileen Howard Dunn, Vice President of Corporate Communications and Community Relations at CVS/pharmacy. "We are not opposed to dispensing medications via the mail. In fact, through our PharmaCare subsidiary, CVS operates one of the largest mail order pharmacies in the country. What we do oppose are prescription plans that severely limit patients' ability to choose their preferred channel of delivery. "
"We sincerely regret any disruption this may cause our customers involved with the Toyota plan," Howard Dunn added. "However, we feel strongly that plans like this one are not in our patients' best interest, as they lose the option to access personal interaction and counseling from a community pharmacist. Our goal is to ensure that patients have access to any channel they prefer at any point in time."
About CVS
CVS is America's #1 retail pharmacy, operating more than 5,300 retail and specialty pharmacy stores in 36 states and the District of Columbia. With more than 40 years of dynamic growth in the retail pharmacy industry, CVS is committed to being the easiest pharmacy retailer for customers to use. CVS has created innovative approaches to serve the healthcare needs of all customers through its CVS/pharmacy stores; its online pharmacy, CVS.com; and its pharmacy benefit management and specialty pharmacy subsidiary, PharmaCare Management Services. General information about CVS is available through the Investor Relations portion of the Company's website, at http://investor.CVS.com.
--30--MA/bo*
CONTACT: CVS/pharmacy Eileen Howard Dunn, 401-770-4561
KEYWORD: RHODE ISLAND INDUSTRY KEYWORD: MEDICAL INSURANCE PHARMACEUTICAL RETAIL CONSUMER/HOUSEHOLD SOURCE: CVS/pharmacy
Copyright Business Wire 2005
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu CVS Health Corpmehr Nachrichten
24.01.25 |
S&P 500-Titel CVS Health-Aktie: So viel Verlust hätte eine CVS Health-Investition von vor 10 Jahren eingebracht (finanzen.at) | |
17.01.25 |
S&P 500-Titel CVS Health-Aktie: So viel Verlust hätte ein Investment in CVS Health von vor 5 Jahren bedeutet (finanzen.at) | |
13.01.25 |
Pluszeichen in New York: S&P 500 zum Handelsende fester (finanzen.at) | |
13.01.25 |
Schwache Performance in New York: S&P 500 zeigt sich schwächer (finanzen.at) | |
13.01.25 |
Börse New York in Rot: So steht der S&P 500 am Montagmittag (finanzen.at) | |
13.01.25 |
NYSE-Handel S&P 500 verbucht zum Start des Montagshandels Abschläge (finanzen.at) | |
10.01.25 |
Minuszeichen in New York: S&P 500 präsentiert sich schlussendlich schwächer (finanzen.at) | |
10.01.25 |
S&P 500-Handel aktuell: S&P 500 notiert am Freitagnachmittag im Minus (finanzen.at) |
Analysen zu CVS Health Corpmehr Analysen
Aktien in diesem Artikel
CVS Health Corp | 51,60 | 0,60% |
Indizes in diesem Artikel
S&P 500 | 6 101,24 | -0,29% | |
NYSE US 100 | 17 129,98 | 1,09% |